Literature DB >> 28378638

Expression signatures of DNA repair genes correlate with survival prognosis of astrocytoma patients.

Juliana Ferreira de Sousa1,2, Raul Torrieri3, Rodolfo Bortolozo Serafim1,2, Luis Fernando Macedo Di Cristofaro1,2, Fábio Dalbon Escanfella2, Rodrigo Ribeiro2, Dalila Lucíola Zanette4,5,6, Maria Luisa Paçó-Larson2, Wilson Araujo da Silva4,5,6,7, Daniela Pretti da Cunha Tirapelli8, Luciano Neder9, Carlos Gilberto Carlotti7,8, Valeria Valente1,2,7.   

Abstract

Astrocytomas are the most common primary brain tumors. They are very resistant to therapies and usually progress rapidly to high-grade lesions. Here, we investigated the potential role of DNA repair genes in astrocytoma progression and resistance. To this aim, we performed a polymerase chain reaction array-based analysis focused on DNA repair genes and searched for correlations between expression patters and survival prognoses. We found 19 genes significantly altered. Combining these genes in all possible arrangements, we found 421 expression signatures strongly associated with poor survival. Importantly, five genes (DDB2, EXO1, NEIL3, BRCA2, and BRIP1) were independently correlated with worse prognoses, revealing single-gene signatures. Moreover, silencing of EXO1, which is remarkably overexpressed, promoted faster restoration of double-strand breaks, while NEIL3 knockdown, also highly overexpressed, caused an increment in DNA damage and cell death after irradiation of glioblastoma cells. These results disclose the importance of DNA repair pathways for the maintenance of genomic stability of high-grade astrocytomas and suggest that EXO1 and NEIL3 overexpression confers more efficiency for double-strand break repair and resistance to reactive oxygen species, respectively. Thereby, we highlight these two genes as potentially related with tumor aggressiveness and promising candidates as novel therapeutic targets.

Entities:  

Keywords:  DNA repair; astrocytoma; genomic instability; glioblastoma; tumor progression

Mesh:

Substances:

Year:  2017        PMID: 28378638     DOI: 10.1177/1010428317694552

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  15 in total

1.  An autoinhibitory role for the GRF zinc finger domain of DNA glycosylase NEIL3.

Authors:  Alyssa A Rodriguez; Jessica L Wojtaszek; Briana H Greer; Tuhin Haldar; Kent S Gates; R Scott Williams; Brandt F Eichman
Journal:  J Biol Chem       Date:  2020-09-02       Impact factor: 5.157

2.  EXO1 overexpression is associated with poor prognosis of hepatocellular carcinoma patients.

Authors:  Yaoyao Dai; Zuxiong Tang; Zongguo Yang; Lan Zhang; Qing Deng; Xiaofeng Zhang; Yongchun Yu; Xing Liu; Junfeng Zhu
Journal:  Cell Cycle       Date:  2018-10-20       Impact factor: 4.534

3.  Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma.

Authors:  Jiaxiu Ma; Jiapei Jin; Huishuang Lu; Jin Zhang; Yalan Li; Xuefei Cai
Journal:  Front Mol Biosci       Date:  2022-06-13

4.  Homologous repair deficiency score for identifying breast cancers with defective DNA damage response.

Authors:  Ahrum Min; Kwangsoo Kim; Kyeonghun Jeong; Seongmin Choi; Seongyeong Kim; Koung Jin Suh; Kyung-Hun Lee; Sun Kim; Seock-Ah Im
Journal:  Sci Rep       Date:  2020-07-27       Impact factor: 4.379

5.  Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.

Authors:  Juan Chen; Ziheng Wang; Xianjuan Shen; Xiaopeng Cui; Yuehua Guo
Journal:  Mol Genet Genomic Med       Date:  2019-05-13       Impact factor: 2.183

6.  DNA repair genes in astrocytoma tumorigenesis, progression and therapy resistance.

Authors:  Juliana Ferreira de Sousa; Rodolfo Bortolozo Serafim; Laura Marise de Freitas; Carla Raquel Fontana; Valeria Valente
Journal:  Genet Mol Biol       Date:  2019-12-13       Impact factor: 1.771

Review 7.  Emerging Roles of DDB2 in Cancer.

Authors:  Pauline Gilson; Guillaume Drouot; Andréa Witz; Jean-Louis Merlin; Philippe Becuwe; Alexandre Harlé
Journal:  Int J Mol Sci       Date:  2019-10-18       Impact factor: 5.923

8.  Downregulation of the DNA Repair Gene DDB2 by Arecoline Is through p53's DNA-Binding Domain and Is Correlated with Poor Outcome of Head and Neck Cancer Patients with Betel Quid Consumption.

Authors:  Yu-Chu Wang; Jau-Ling Huang; Ka-Wo Lee; Hsing-Han Lu; Yuan-Jen Lin; Long-Fong Chen; Chung-Sheng Wang; Yun-Chiao Cheng; Zih-Ting Zeng; Pei-Yi Chu; Chang-Shen Lin
Journal:  Cancers (Basel)       Date:  2020-07-25       Impact factor: 6.639

9.  Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells.

Authors:  Alex W Klattenhoff; Megha Thakur; Christopher S Chu; Debolina Ray; Samy L Habib; Dawit Kidane
Journal:  Oncotarget       Date:  2017-12-04

10.  DNA Repair Molecular Beacon assay: a platform for real-time functional analysis of cellular DNA repair capacity.

Authors:  Jianfeng Li; David Svilar; Steven McClellan; Jung-Hyun Kim; Eun-Young Erin Ahn; Conchita Vens; David M Wilson; Robert W Sobol
Journal:  Oncotarget       Date:  2018-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.